囊性纤维化患者内镜鼻窦手术后肺功能改善
本研究回顾性分析1996年至2018年间接受内镜鼻窦手术(ESS)的188例囊性纤维化(CF)患者共427次手术,按基线%FEV1分为重度(<40%)、中度(40%-70%)和轻度(>70%)肺病。多变量混合效应模型显示,重度、中度和基线%FEV1 70%-80%的轻度患者术后%FEV1分别提高8.1%、3.0%和7.3%,且改善维持至术后12个月;基线%FEV1>80%者无改善。
要点
- CF患者ESS术后肺功能改善因肺病严重程度而异。
- 重度肺病患者%FEV1提高8.1%,中度提高3.0%。
- 基线%FEV1 70%-80%的轻度患者提高7.3%,>80%者无改善。
核心结论
- 控制重要混杂因素后,ESS可改善重度、中度及部分轻度CF患者的肺功能,并维持至术后12个月。
研究设计与样本
- 回顾性病历审查,纳入1996年1月至2018年7月接受ESS的CF患者,最终分析188例患者共427次手术。
主要发现
- 术后%FEV1在重度肺病患者中提高8.1%(95%CI:2.3,13.9%)。
- 术后%FEV1在中度肺病患者中提高3.0%(95%CI:0.7,5.2%)。
- 基线%FEV1 70%-80%的轻度患者术后%FEV1提高7.3%(95%CI:4.2,10.5%)。
- 基线%FEV1>80%的患者未见改善。
关键数值与推荐
- 肺病严重程度按%FEV1划分:<40%为重度,40%-70%为中度,>70%为轻度。
临床怎么用
- 对于重度或中度肺病的CF患者,ESS可能带来肺功能获益。
- 基线%FEV1 70%-80%的轻度患者也可考虑ESS以改善肺功能。
- 基线%FEV1>80%的轻度患者术后肺功能未见改善。
局限性
- 本研究为回顾性病历审查,证据等级为4级。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE/HYPOTHESIS: To compare pre-and post-operative pulmonary function relative to disease severity in cystic fibrosis (CF) patients following endoscopic sinus surgery (ESS). STUDY DESIGN: Retrospective chart review. METHODS: Patients with CF who underwent ESS between January 1996 and July 2018 were identified, with subsequent study exclusions based upon surgical indications or incomplete records. CF disease severity was based upon percentage predicted of forced expiratory volume in 1 second (%FEV1) with <40% considered severe disease, 40% to 70% as moderate disease, and >70% as mild disease. The changes in %FEV1 before and after ESS were examined using multivariable mixed-effects models controlling for age, gender, genotype, medications, nutritional status, diabetes status, microbiology results, extent of surgery, and number of surgeries. RESULTS: A total of 427 surgeries were performed in 188 patients during the study period. Mean age at first ESS was 12.7 years (SD 6.0 years, range 4-38) and 54.8% were females. The effect of ESS varied by severity of lung disease. After surgery, %FEV1 increased by 8.1% (95% CI: 2.3, 13.9%) among patients with severe lung disease and by 3.0% (95% CI: 0.7, 5.2%) among patients with moderate disease. %FEV1 also increased by 7.3% (95% CI: 4.2, 10.5%) among patients with mild disease whose %FEV1 value was 70% to 80% at baseline. No improvement was observed in patients with a baseline %FEV1 >80%. CONCLUSIONS: When controlling for important confounding factors, lung function improved following ESS among CF patients with severe and moderate disease and in select patients with mild disease. This improvement was sustained at 12 months following surgery. LEVEL OF EVIDENCE: 4 Laryngoscope, 131:1930-1938, 2021.
引用
- Kawai K, Dombrowski N, Sawicki GS, et al. Improvement of Pulmonary Function in Cystic Fibrosis Patients following Endoscopic Sinus Surgery. Laryngoscope. 2021. PMID: 33538334. doi:10.1002/lary.29409
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。